Computational Service
Cell Line Models
Scoped After Feasibility Review
Service Overview
Overexpression lines fail in predictable ways — expression too high to be physiological, silencing over passage, a tag that disrupts localisation, or toxicity that selects for low expressors. Construct design addresses each of these before transfection. We design the cassette, optimise the coding sequence for the host, select promoter strength appropriate to the intended use, and specify how expression level and stability will be confirmed.
Key Features & Advantages
Promoter Strength Chosen Deliberately
Strong constitutive promoters are not always right. Where physiological expression matters, weaker or endogenous-like promoters are proposed, with the trade-off stated.
Inducible Systems Where Control Matters
For toxic or dosage-sensitive genes, inducible architectures are designed with attention to leakiness, which is the usual reason such systems disappoint.
Tag Placement Modelled
Tag terminus and linker are chosen against predicted effects on folding, secretion signals and localisation rather than by convention.
Silencing Risk Considered
Element choice and integration strategy take account of long-term expression stability, since silencing over passage is a common late failure.
Where This Service Is Used
1Generating stable lines expressing a target for assay development or screening
2Producing recombinant protein from a stable pool or clonal line
3Complementation and rescue experiments in knockout backgrounds
4Expressing variants in parallel to compare their functional consequences
5Building reporter lines for pathway activity readouts
How the Work Is Performed
1Coding sequence analysis and codon optimisation for the host cell line
2Promoter, enhancer, polyadenylation and intron element selection for the intended expression level
3Inducible system design where temporal or dosage control is needed, with leakiness assessed
4Tag and linker design with structural assessment of the likely functional impact
5Selection marker strategy and integration approach, including targeted integration where available
6Expression verification plan covering transcript, protein and functional readouts
What We Need From You
1Coding sequence or accession, with the isoform and any required variants
2Host cell line and the vector system available to you
3Target expression level and whether it needs to be inducible or titratable
4Intended downstream use, since assay lines and production lines have different requirements
What You Receive
1Complete annotated expression cassette design ready for synthesis or cloning
2Codon-optimised coding sequence with the optimisation criteria documented
3Tag and linker recommendation with the structural rationale
4Selection and integration strategy with expected timelines
5Verification plan covering expression level, stability over passage and functional confirmation
Questions We Are Asked Before Scoping
Should we use the strongest promoter available?
▸Usually not. Overexpression far above physiological level produces artefacts including mislocalisation and aggregation. We match promoter strength to the question being asked.
Why did our line lose expression over time?
▸Silencing of the integrated cassette is common, particularly with certain promoters and random integration. Element choice and targeted integration reduce the risk, and we design for it.
N-terminal or C-terminal tag?
▸It depends on the protein — signal peptides, termini involved in function and localisation determinants all matter. We model both and recommend, and where it is genuinely uncertain we suggest making both.
Interpretation and Limitations
This is a computational (in silico) service. Designs and predictions prioritise hypotheses and direct experimental effort; they do not by themselves establish that an edit, construct, molecule or assay will perform as intended. Laboratory execution — editing, cloning, expression, synthesis and testing — is planned with you and carried out by your own team or a qualified partner. Deliverables are for research use only and are not intended for diagnostic or therapeutic use.
Is This the Right Service for You?
Choose this when
A stable line expressing a target is needed for assay development or screening
Complementation or rescue experiments require controlled expression
Variants must be expressed in parallel for functional comparison
Consider another service when
Expression must stay under endogenous control
Stable Knock-in Cell Line Design The target is a G protein-coupled receptor with assay requirements
GPCR Cell Line & Assay Design What Goes Wrong, and How We Handle It
These are the failure modes that produce confident-looking results which do not survive the next experiment. Each one is designed against rather than discovered afterwards.
Expression so far above physiological level that the biology becomes artefact
Promoter strength is matched to the intended use, with the trade-off stated rather than defaulting to the strongest available.
Silencing of the cassette over passage
Element choice and integration strategy account for long-term stability, and verification over passage is written into the plan.
A tag that disrupts folding, secretion or localisation
Both termini are assessed structurally and the placement least likely to interfere is recommended.
A Worked Example
A toxic transgene that selected for low expressors
The situation
Stable pools lost expression within a few passages whenever a strong constitutive promoter was used.
What the work involved
The transgene was assessed for likely toxicity, an inducible architecture was designed with leakiness as an explicit criterion, and integration strategy was revised.
What came back
An inducible cassette with measurable background, plus a weaker constitutive alternative for comparison. Verification over ten passages was built into the delivered plan.
Illustrative of the shape this work takes. Details are generalised, no client or target is identified, and scope and outcome vary with the system in question.
Service Workflow
1
Scientific Consultation
We discuss the objective, the decision it supports and the material and data you already hold.
2
Feasibility Review
We check that the target, system and available information can support the approach, and say plainly where they cannot.
3
Technical Proposal
Scope, methods, deliverables, timeline and price are confirmed in writing, together with the limitations we expect to report.
4
Design and Analysis
The design work runs on documented tools and parameters, with quality checks and alternatives compared where that is informative.
5
Delivery and Follow-Up
You receive the designs, the supporting analysis and a validation plan, plus support interpreting the results once the experiments run.
Service Process
1
Online Consultation
›
2
Solution Matching
›
3
Service Contract
›
4
Project Execution
›
5
Data Delivery
Specifications & Turnaround
Note: ICDMO delivers computational (in silico) services. Results prioritise hypotheses for testing; they do not by themselves establish binding, biological activity, efficacy or safety. All deliverables are for research use only and are not intended for diagnostic or therapeutic use. Downstream experimental work is scoped separately and executed through qualified partners.
Get a Custom Quote
Our scientific team responds within 24 hours with a detailed technical proposal and pricing tailored to your project.
Contact Us Online ConsultationStandard Deliverables
✓Sequence-verified final product
✓Full QC documentation
✓Certificate of Analysis (CoA)
✓Electronic data files
✓Project completion report
Why ICDMO?
Computational CDMO Focus
Reproducible, Versioned Pipelines
Confidence & Limitations Reported
Experiment-Aware Recommendations
Response Within One Business Day